Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Photodynamic therapy (its current status, problems and prospects)].

Kats VA, Litvin GD, Nazirov ShB, Riazhskiĭ GG, Stranadko EF, Iagubov AS, Gradiushko AT, Ivanov AV.

Vopr Onkol. 1992;38(12):1403-12. Review. Russian. No abstract available.

PMID:
1343178
2.

Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects.

Jarvi MT, Niedre MJ, Patterson MS, Wilson BC.

Photochem Photobiol. 2006 Sep-Oct;82(5):1198-210. Review.

PMID:
16808593
3.

Molecular, cellular, and tissue responses following photodynamic therapy.

Gomer CJ, Ferrario A, Hayashi N, Rucker N, Szirth BC, Murphree AL.

Lasers Surg Med. 1988;8(5):450-63. Review.

PMID:
2976443
4.

Clinical and preclinical photodynamic therapy.

Fisher AM, Murphree AL, Gomer CJ.

Lasers Surg Med. 1995;17(1):2-31. Review.

PMID:
7564853
5.

[Photosensitized formation of singlet oxygen in water solutions of covalent porphyrin-antibody conjugates].

Egorov SIu, Krasnovskiĭ AA Jr, Pankovskiĭ DB, Ponomarev GV, Savitskiĭ AP.

Biull Eksp Biol Med. 1990 Apr;109(4):349-51. Russian.

PMID:
2386825
6.

Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy.

Patterson MS, Madsen SJ, Wilson BC.

J Photochem Photobiol B. 1990 Apr 1;5(1):69-84.

PMID:
2111394
7.

Photodynamic therapy.

Dougherty TJ.

Clin Chest Med. 1985 Jun;6(2):219-36. Review.

PMID:
3161682
8.

[Molecular biological mechanisms of photodynamic therapy].

Kirvialene VA, Lukshene ZhB, Iuodka BA.

Nauchnye Doki Vyss Shkoly Biol Nauki. 1989;(5):5-14. Review. Russian.

PMID:
2527567
9.

Photodynamic therapy: tumor targeting with adenoviral proteins.

Allen CM, Sharman WM, La Madeleine C, Weber JM, Langlois R, Ouellet R, van Lier JE.

Photochem Photobiol. 1999 Oct;70(4):512-23.

PMID:
10546549
10.

[History of photodynamic therapy--past, present and future].

Kato H.

Gan To Kagaku Ryoho. 1996 Jan;23(1):8-15. Review. Japanese.

PMID:
8546474
11.

Photodynamic assay of light distributions in tissue phantoms.

Mason LW, Welch AJ, van Gemert MJ.

Lasers Surg Med. 1988;8(5):521-6.

PMID:
2976447
12.

Melatonin generates singlet oxygen on laser irradiation but acts as a quencher when irradiated by lamp photolysis.

Maharaj DS, Molell H, Antunes EM, Maharaj H, Maree DM, Nyokong T, Glass BD, Daya S.

J Pineal Res. 2005 Apr;38(3):153-6.

PMID:
15725335
13.

Vascular and cellular targeting for photodynamic therapy.

Chen B, Pogue BW, Hoopes PJ, Hasan T.

Crit Rev Eukaryot Gene Expr. 2006;16(4):279-305. Review.

PMID:
17206921
14.

Photodynamic therapy: status and potential.

Dougherty TJ.

Oncology (Williston Park). 1989 Jul;3(7):67-73; discussion 74, 77-8. Review.

PMID:
2534944
15.

Photodynamic therapy.

Smith RP.

Curr Probl Cancer. 2002 Mar-Apr;26(2):67-108. Review. No abstract available.

PMID:
12042761
16.

Photodynamic therapy and cancer of the esophagus.

Marcon NE.

Semin Oncol. 1994 Dec;21(6 Suppl 15):20-3. Review.

PMID:
7992103
17.

Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma.

Yamamoto J, Yamamoto S, Hirano T, Li S, Koide M, Kohno E, Okada M, Inenaga C, Tokuyama T, Yokota N, Terakawa S, Namba H.

Clin Cancer Res. 2006 Dec 1;12(23):7132-9.

18.

New technology for deep light distribution in tissue for phototherapy.

Chen J, Keltner L, Christophersen J, Zheng F, Krouse M, Singhal A, Wang SS.

Cancer J. 2002 Mar-Apr;8(2):154-63.

PMID:
11999949
19.

Future directions of laser phototherapy for diagnosis and treatment of malignancies: fantasy, fallacy, or reality?

Castro DJ, Saxton RE, Lufkin RB, Haugland RP, Zwarun AA, Fetterman HR, Soudant J, Castro DJ, Ward PH, Kangarloo H.

Laryngoscope. 1991 Jul;101(7 Pt 2 Suppl 55):1-10. Review.

PMID:
2062168
20.

Photodynamic therapy and some clinical applications in oncology.

Dima VF, Ionescu MD, Balotescu C, Dima SF.

Roum Arch Microbiol Immunol. 2002 Jul-Sep;61(3):159-205. Review.

PMID:
14752983

Supplemental Content

Support Center